Objective: To evaluate the incidence of Borrelia burgdorferi infection in h
umans with erythema migrans (EM) in 2 southeastern states.
Design: Prospective case series.
Setting: Family medicine practice at academic center.
Patients: Twenty-three patients with solitary EM lesions meeting Centers fo
r Disease Control and Prevention (CDC) criteria for Lyme disease.
Interventions: Patients underwent clinical and serologic evaluation for evi
dence of B burgdorferi infection. All lesions underwent photography, biopsy
, culture and histopathologic and polymerase chain reaction analysis for B
burgdorferi infection. Patients were treated with doxycycline hyclate and f
ollowed up clinically and serologically.
Main Outcome Measures: Disappearance of EM lesions and associated clinical
symptoms in response to antibiotic therapy; short-term and follow-up serolo
gic assays for diagnostic antibody; growth of spirochetes from tissue biops
y specimens in Barbour-Stoenner-Kelly II media; special histopathologic sta
ins of tissue for spirochetes; and polymerase chain reaction assays of tiss
ue biopsy specimens for established DNA sequences of B burgdorferi.
Results: The EM. lesions ranged from 5 to 20 cm (average, 9.6 cm). Five pat
ients (22%) had mild systemic symptoms. All lesions and associated symptoms
resolved with antibiotic therapy. Overall, 7 patients (30%) had some evide
nce of B burgdorferi infection. Cultures from 1 patient (4%) yielded spiroc
hetes, characterized as Borrelia garinii, a European strain not known to oc
cur in the United States; 3 patients (13%) demonstrated spirochetallike for
ms on special histologic stains; 5 patients (22%) had positive polymerase c
hain reaction findings with primers for flagellin DNA sequences; and 2 pati
ents (9%) were seropositive for B burgdorferi infection using recommended 2
-step CDC methods. No late clinical sequelae were observed after treatment.
Conclusions: The EM lesions we observed are consistent with early Lyme dise
ase occurring elsewhere, but laboratory confirmation of B burgdorferi infec
tion is lacking in at least 16 cases (70%) analyzed using available methods
. Genetically variable strains of B burgdorferi, alternative Borrelia speci
es, or novel, uncharacterized infectious agents may account for most of the
observed EM lesions.